| Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis N Acosta, A Heirali, R Somayaji, MG Surette, ML Workentine, CD Sibley, ... Thorax 73 (11), 1016-1025, 2018 | 85 | 2018 |
| Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis FJ Whelan, AA Heirali, L Rossi, HR Rabin, MD Parkins, MG Surette PloS one 12 (3), e0172811, 2017 | 76 | 2017 |
| The effects of inhaled aztreonam on the cystic fibrosis lung microbiome AA Heirali, ML Workentine, N Acosta, A Poonja, DG Storey, R Somayaji, ... Microbiome 5, 1-14, 2017 | 55 | 2017 |
| A longitudinal characterization of the Non-Cystic Fibrosis Bronchiectasis airway microbiome TE Woo, R Lim, AA Heirali, N Acosta, HR Rabin, CH Mody, R Somayaji, ... Scientific reports 9 (1), 6871, 2019 | 51 | 2019 |
| Assessment of the microbial constituents of the home environment of individuals with cystic fibrosis (CF) and their association with lower airways infections A Heirali, S McKeon, S Purighalla, DG Storey, L Rossi, G Costilhes, ... PLoS One 11 (2), e0148534, 2016 | 31 | 2016 |
| The effects of cycled inhaled aztreonam on the cystic fibrosis (CF) lung microbiome AA Heirali, N Acosta, DG Storey, ML Workentine, R Somayaji, ... Journal of Cystic Fibrosis 18 (6), 829-837, 2019 | 26 | 2019 |
| Sputum microbiota in adults with CF associates with response to inhaled tobramycin A Heirali, C Thornton, N Acosta, R Somayaji, IL Lapointe, D Storey, ... Thorax 75 (12), 1058-1064, 2020 | 24 | 2020 |
| Cystic Fibrosis Patients Infected With Epidemic Pseudomonas aeruginosa Strains Have Unique Microbial Communities N Acosta, B Waddell, A Heirali, R Somayaji, MG Surette, ML Workentine, ... Frontiers in Cellular and Infection Microbiology 10, 173, 2020 | 21 | 2020 |
| Bugs as drugs: The role of microbiome in cancer focusing on immunotherapeutics DV Araujo, GA Watson, M Oliva, A Heirali, B Coburn, A Spreafico, LL Siu Cancer Treatment Reviews 92, 102125, 2021 | 18 | 2021 |
| First-in-class Microbial Ecosystem Therapeutic 4 (MET4) in combination with immune checkpoint inhibitors in patients with advanced solid tumors (MET4-IO trial) A Spreafico, AA Heirali, DV Araujo, TJ Tan, M Oliva, PHH Schneeberger, ... Annals of Oncology 34 (6), 520-530, 2023 | 14 | 2023 |
| Resveratrol intervention attenuates chylomicron secretion via repressing intestinal FXR-induced expression of scavenger receptor SR-B1 J Pang, F Raka, AA Heirali, W Shao, D Liu, J Gu, JN Feng, C Mineo, ... Nature communications 14 (1), 2656, 2023 | 9 | 2023 |
| First-in-class microbial ecosystem therapeutics 4 (MET4) in metastatic solid cancer patients treated with immunotherapy: MET4-IO. DV Araujo, M Oliva Bernal, TJY Tan, AA Heirali, PHH Schneeberger, ... Journal of Clinical Oncology 38 (15_suppl), 3098-3098, 2020 | 6 | 2020 |
| Effect of freezing sputum on Pseudomonas aeruginosa population heterogeneity A Poonja, A Heirali, M Workentine, DG Storey, R Somayaji, HR Rabin, ... Journal of Cystic Fibrosis 16 (3), 353-357, 2017 | 6 | 2017 |
| Principles and terminology for host–microbiome–drug interactions A Heirali, S Moossavi, MC Arrieta, B Coburn Open Forum Infectious Diseases 10 (5), ofad195, 2023 | 2 | 2023 |
| Customized autoantibodies (autoAbs) profiling to predict and monitor immune-related adverse events (irAEs) in patients receiving immune checkpoint inhibitors (ICI). S Genta, S Keshavarzi, N Yee, A Heirali, AR Hansen, LL Siu, S Saibil, ... Journal of Clinical Oncology 40 (16_suppl), 2528-2528, 2022 | 2 | 2022 |
| Autoimmune paneLs as prEdictors of toxicity in patients TReated with immune checkpoint inhibiTors (ALERT) S Genta, K Lajkosz, NR Yee, P Spiliopoulou, A Heirali, AR Hansen, ... Journal of Experimental & Clinical Cancer Research 42 (1), 276, 2023 | 1 | 2023 |
| Safety, Immunologic, and Clinical Activity of Durvalumab in Combination with Olaparib or Cediranib in Advanced Leiomyosarcoma: Results of the DAPPER Clinical Trial. A Salawu, BX Wang, M Han, C Geady, A Heirali, HK Berman, TD Pfister, ... Clinical Cancer Research 29 (20), 4128-4138, 2023 | 1 | 2023 |
| Dietary resveratrol intervention improves lipid homeostasis via attenuating HFD-induced fecal chenodeoxycholic acid and jejunum SR-B1 elevation J Pang, F Raka, AA Heirali, W Shao, D Liu, J Gu, JN Feng, C Mineo, ... | 1 | 2022 |
| Prospective manipulation of the gut microbiome with Microbial Ecosystem Therapeutic 4 (MET4) in locoregionally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC … GA Watson, A Heirali, M Oliva Bernal, K Cochrane, E Allen-Vercoe, ... Journal of Clinical Oncology 39 (15_suppl), 6059-6059, 2021 | 1 | 2021 |
| EPIDEMIC PSEUDOMONAS AERUGINOSA: A DRIVING FORCE IN THE CYSTIC FIBROSIS (CF) MICROBIOME? APN Amador, A Heirali, R Somayaji, B Waddell, M Surette, H Rabin, ... PEDIATRIC PULMONOLOGY 51, 330-330, 2016 | 1 | 2016 |
